Elixir Pharmacueticals Postpones IPO

As speculated on the SI blog on January 8th, Elixir Pharmaceuticals has been forced to postpone its IPO, scheduled for this week, as plunging equity markets made a successful offering unrealistic. It is not clear when, or if, the IPO will move forward. Interestingly, it appears that underwriters pulled the plug at the last minute as a NASDAQ ticker symbol, ELXR, was set up today. It is unclear how ELXR will respond to its failed capital raising efforts. Timing is everything.